EW
PFE icon

Elyxium Wealth’s Pfizer PFE Stock Holding History

Elyxium Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$461K Sell
16,419
-366
-2% -$9.74K 0.15% 104
2025
Q4 		$418K Sell
16,785
-5,446
-24% -$137K 0.12% 118
2025
Q3 		$566K Sell
22,231
-2,147
-9% -$53K 0.2% 89
2025
Q2 		$591K Sell
24,378
-868
-3% -$20.2K 0.22% 86
2025
Q1 		$640K Buy
25,246
+13,144
+109% +$344K 0.28% 73
2024
Q4 		$321K Sell
12,102
-22,468
-65% -$609K 0.2% 70
2024
Q3 		$1M Buy
+34,570
New +$1.01M 0.55% 40

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Elyxium Wealth's PFE Position: Q1 2026 in Review

Elyxium Wealth reduced its Pfizer (PFE) stake by 2.2% in Q1 2026, selling an estimated $9.74K and leaving 16,419 shares worth $461K. The position accounts for 0.15% of the portfolio, ranked #104.

Elyxium Wealth first reported a position in PFE in Q3 2024 and has held it in 7 quarters since. The position peaked at $1M in Q3 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Elyxium Wealth held 16,419 shares of Pfizer worth $461K as of Q1 2026.
  • Elyxium Wealth sold 366 Pfizer shares in Q1 2026, an estimated $9.74K.
  • Pfizer made up 0.15% of Elyxium Wealth's portfolio in Q1 2026, its #104 holding.
  • Elyxium Wealth first reported a position in Pfizer in Q3 2024 and has held it in 7 quarters since.
  • Elyxium Wealth's Pfizer position peaked at $1M in Q3 2024.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.